168 related articles for article (PubMed ID: 6803394)
1. Characteristics of urinary glycosaminoglycans excreted by a patient with the Hurler-Scheie compound syndrome.
Kimura A; Hayashi S; Koseki M; Tsurumi K
Tohoku J Exp Med; 1982 Jan; 136(1):61-6. PubMed ID: 6803394
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dermatan sulfate and heparan sulfate in the urine of a patient with the Hunter syndrome.
Kimura A; Hayashi S; Tsurumi K
Tohoku J Exp Med; 1980 Jul; 131(3):227-39. PubMed ID: 6447930
[TBL] [Abstract][Full Text] [Related]
3. Chemical definition of the mucopolysaccharidoses.
Constantopoulos G; Dekaban AS
Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832
[TBL] [Abstract][Full Text] [Related]
4. Comparative structural studies of urinary glycosaminoglycans in the Hurler and Hunter syndromes.
Ramage P; Cunningham WL
Biochim Biophys Acta; 1975 Dec; 411(2):325-33. PubMed ID: 127616
[TBL] [Abstract][Full Text] [Related]
5. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
Hu P; Fang L; Chess EK
Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of peptidoglycans in urine from patients with mucopolysaccharidoses.
Tanaka Y; Takazono I
Int J Biochem; 1984; 16(5):435-46. PubMed ID: 6233194
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.
Satake S; Ototani N; Isemura M; Yosizawa Z
Tohoku J Exp Med; 1983 May; 140(1):89-96. PubMed ID: 6408765
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Fuller M; Meikle PJ; Hopwood JJ
Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
[TBL] [Abstract][Full Text] [Related]
9. Identification of glycosaminoglycans using high-performance liquid chromatography on a hydroxyapatite column.
Narita H; Takeda Y; Takagaki K; Nakamura T; Harata S; Endo M
Anal Biochem; 1995 Nov; 232(1):133-6. PubMed ID: 8600821
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biochemical effects of long-term vitamin A administration to a patient with Hurler-Scheie compound.
Wannmacher CM; Wajner M; Giugliani R; Costa MG; Giugliani ER; Castro JZ
Braz J Med Biol Res; 1984; 17(1):43-7. PubMed ID: 6236861
[TBL] [Abstract][Full Text] [Related]
11. Analysis of glycosaminoglycan chains from different proteoglycan populations in human embryonic skin fibroblasts.
Schmidtchen A; Fransson LA
Eur J Biochem; 1992 Sep; 208(2):537-46. PubMed ID: 1521543
[TBL] [Abstract][Full Text] [Related]
12. Chemical structure of urinary dermatan sulfate excreted by a patient with the Hunter syndrome.
Kimura A; Hayashi S; Tsurumi K
Tohoku J Exp Med; 1980 Jul; 131(3):241-7. PubMed ID: 6774445
[TBL] [Abstract][Full Text] [Related]
13. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
de Ru MH; van der Tol L; van Vlies N; Bigger BW; Hollak CE; Ijlst L; Kulik W; van Lenthe H; Saif MA; Wagemans T; van der Wal WM; Wanders RJ; Wijburg FA
J Inherit Metab Dis; 2013 Mar; 36(2):247-55. PubMed ID: 22991166
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of glycosaminoglycans and albumin in experimental diabetes mellitus.
Cadaval RA; Kohlman O; Michelacci YM
Glycobiology; 2000 Feb; 10(2):185-92. PubMed ID: 10642610
[TBL] [Abstract][Full Text] [Related]
15. Molecular size difference of urinary heparan sulfates from normal individuals and genetic mucopolysaccharidoses.
Taniguchi N; Miyawaki T; Moriya N; Okuda N
Clin Chim Acta; 1975 May; 60(3):363-9. PubMed ID: 124636
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of hepatic glycosaminoglycans in the early stages of galactosamine hepatitis: a rapid decline of heparan sulfate is followed by elevation of chondroitin sulfate and dermatan sulfate.
Gressner AM; Köster-Eiserfunke W
J Clin Chem Clin Biochem; 1981 Jun; 19(6):363-70. PubMed ID: 6456325
[TBL] [Abstract][Full Text] [Related]
17. Sulfated glycosaminoglycans (GAG) in the developing mouse brain. Quantitative aspects on the metabolism of total and individual sulfated GAG in vivo.
Burkart T; Wiesmann UN
Dev Biol; 1987 Apr; 120(2):447-56. PubMed ID: 3104114
[TBL] [Abstract][Full Text] [Related]
18. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome.
Pereira DA; Aguiar JA; Hagiwara MK; Michelacci YM
Biochim Biophys Acta; 2004 Apr; 1672(1):1-11. PubMed ID: 15056487
[TBL] [Abstract][Full Text] [Related]
19. The heterogeneity of dermatan sulfate and heparan sulfate in rat liver and a shift in the glycosaminoglycan contents in carbon tetrachloride-damaged liver.
Suzuki S; Suzuki S; Nakamura N; Koizumi T
Biochim Biophys Acta; 1976 Mar; 428(1):166-181. PubMed ID: 130930
[TBL] [Abstract][Full Text] [Related]
20. Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum.
Maccari F; Gheduzzi D; Volpi N
Clin Chem; 2003 Mar; 49(3):380-8. PubMed ID: 12600949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
